Structural trends among second-generation voltage-gated sodium channel blockers.
Kemp
Mark I
MI
Pfizer Global Research & Development, Sandwich, Kent, UK.
D000818:Animals; D055808:Drug Discovery; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects; D015394:Molecular Structure; D026941:Sodium Channel Blockers / Q000737:chemistry* / Q000494:pharmacology; D015222:Sodium Channels / Q000378:metabolism; D013329:Structure-Activity Relationship
D026941:Sodium Channel Blockers; D015222:Sodium Channels